Pakistan's First and only MHRA CGMP Certified Company


(Clopidogrel + Enteric Coated Aspirin)

With Double Core Tablet Technology to Erase Risks from Your Life

Valvprin® is an antiplatelet drug used for the treatment of atherosclerosis. It reduces the risks of heart attack and strokes by treating blood circulation disorder and acute coronary syndromes and keeping the blood vessels open and clot free.

Valvprin® is globally recommended combination that has:

  • Reduced the risk of MI, Stroke, and Death relatively by 27%.
  • Synergetic effect in preventing thrombus (clot) formation.
  • Significantly reduced the risk of cardio-cerebro-vascular events.
  • More potent antithrombotic effects than conventional blood thinners.
  • Ideal long term treatment for Acute Coronary Syndrome (ACS).

Active Ingredients

Valvprin® contains clopidogrel and aspirin, both of which are powerful platelet aggregation inhibitors. These prevent platelets (blood cells) from sticking together and forming blood clots in arteries and veins.



Valvprin® is used for the treatment of the following conditions:

  • Myocardial Infarction – Heart Attack: It occurs due to lack of blood flow, when an epicardial artery is blocked usually by a blood clot.
  • Stroke – Brain Attack: It happens when a blood vessel feeding the brain gets clogged or bursts.
  • Peripheral Artery Disease – It is generally derived from the presence of occlusive arterial disease, which causes inadequate blood flow to the limbs.


Valvprin® has a convenient once-a-day dosage.